Hirotaka Kurebayashi

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., Sumitomo Pharma Oncology, Inc., Astrazeneca Aktiebolag. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirotaka Kurebayashi. Retrieved from https://idiyas.com/inventor/hirotaka-kurebayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 44(Granted Patents)

Location History:

Osaka, JP (2016 - 2024)
Minoh, JP (2022 - 2024)

Company Filing History:

4 out of 110

Sumitomo Dainippon Pharma Co., Ltd.

patents

2 out of 11

Sumitomo Pharma Oncology, Inc.

patents

1 out of 6

Astrazeneca Aktiebolag

patents

4. 1 out of 11

Sumitomo Dainippon Pharma Oncology, Inc.

patents

5. 1 out of 66

Sumitomo Pharma Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12077554 - CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer (2024-09-03),

2. 12077510 - Carboxylic acid compounds (2024-09-03),

3. 11530231 - CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer (2022-12-20),

4. 11299465 - Carboxylic acid compounds (2022-04-12),

5. 11034710 - CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer (2021-06-15),

6. 10562861 - Carboxylic acid compounds (2020-02-18),

7. 10150743 - Carboxylic acid compounds (2018-12-11),

8. 9376398 - Carboxylic acid compounds (2016-06-28),

Title: Hirotaka Kurebayashi: Innovator in Pharmaceutical Compounds

Introduction

Hirotaka Kurebayashi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on innovative compounds that have the potential to treat various medical conditions.

Latest Patents

Kurebayashi's latest patents include advancements in carboxylic acid compounds. These compounds are designed for pharmaceutical applications, particularly in treating allergic diseases, autoimmune diseases, viral diseases, and cancer. Another notable patent involves CDK9 inhibitors and their polymorphs, which are crucial for cancer treatment. These patents not only detail the compounds but also the methods for their preparation and use in pharmaceutical compositions.

Career Highlights

Throughout his career, Kurebayashi has worked with reputable companies such as Sumitomo Dainippon Pharma Co., Ltd. and Sumitomo Pharma Oncology, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Kurebayashi has collaborated with notable colleagues, including Seiji Hori and Futoshi Hasegawa. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Hirotaka Kurebayashi is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.